Intracellular delivery iii: market entry barriers of nanomedicines
Éditeur :
Springer International Publishing AG
ISBN :
9783319828466
Date de publication :
12 juil. 2018
Dimensions :
23,5 x 15,5 cm
Langue :
Anglais
Pays d'origine :
Suisse
It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available.